跳至主要内容
临床试验/NL-OMON45533
NL-OMON45533尚未招募不适用

Online Adaptive stereotactic radiotherapy for abdominopelvic lymphnode oligometastasis. - STEA

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 53 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Indication to SBRT after discussion in Institutional Tumor Board
  • * Patients with abdominal and/or pelvic lymph node metastases of solid tumors
  • * No more than 5 metastatic lesions in no more than 2 organs and a controlled primary tumor site
  • * Diagnostic imaging includes at least a PET-scan and CT *thorax/abdomen, of which one is not older than 4 weeks at the time of referral for SBRT.
  • * Primary tumor must be treated at least 4 months before the diagnosis of the metastasis
  • * Patients must be 18 years or older

排除标准

  • * Prior radiotherapy in the same field.
  • * Second primary malignancy except in situ carcinoma of the cervix, adequately
  • treated non-melanoma skin cancer, or other malignancy treated at least 3 years
  • previously without evidence of recurrence.
  • * Pregnancy.
  • * Serious concomitant systemic disorders that would compromise the safety of the
  • patient or his/her ability to complete the study, at the discretion of the investigator.

研究者

相似试验